The effect of preferentially expressed antigen in melanoma (PRAME) expression status on survival in stage II and stage III colon cancer.


Ogul A., Paydas S., Doran F., Erdogan K. E., Tohumcuoglu M., Buyuksimsek M., ...More

Journal of B.U.ON. : official journal of the Balkan Union of Oncology, vol.26, pp.992-1001, 2021 (SCI-Expanded) identifier identifier